Synapse - Works

Results (115370)

Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045)

Meeting Abstract

Hwang, E.; Kilburn, L.; Mitchell, D.; Lin, T.; Poussaint, T. Y.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma

Meeting Abstract

Lassman, A.; Alexander, B.; Berry, D.; Berry, N.; Buxton, M.; Colman, H.; Gan, H.; de Groot, J.; de la Fuente, M.; Drappatz, J.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Alliance A071401: Genomically guided phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations

Meeting Abstract

Brastianos, P.; Dooley, K.; Geyer, S.; Gerstner, E.; Kaufmann, T.; Iafrate, A. J.; Martinez-Lage, M.; Milhem, M.; Welch, M.; Kaley, T.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)

Meeting Abstract

Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas

Meeting Abstract

Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

IDH-mutant glioma patients treated with vorasidenib: Ongoing data from the vorasidenib expanded access program

Meeting Abstract

Cloughesy, T.; Peters, K.; Colman, H.; Taylor, J.; Mellinghoff, I.; Shih, H.; Chacar, C.; Dewey, J.; Wen, P.
Neuro-Oncology (2024)

Fulltext@MSK | Save

Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician's choice systemic therapy in subjects with breast cancer brain metastases (SOLARA)

Meeting Abstract

Shen, C.; Abdou, Y.; Chen, L.; Tan, X.; Gupta, G.; Lynce, F.; Lobbous, M.; Stringer-Reasor, E.; Anders, C.
Neuro-Oncology (2024)

Fulltext@MSK | Save

A phase 1, randomized, perioperative trial of vorasidenib and ivosidenib in IDH1-mutant diffuse glioma: Updated results

Meeting Abstract

Mellinghoff, I.; Wen, P.; Taylor, J.; Taylor, E.; Arrillaga-Romany, I.; Ellingson, B.; Mahboub-Johnson, P.; Baron, E.; Hassan, I.; Steelman, L.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Phase 1 dose finding study evaluating the safety, tolerability, and efficacy of iopofosine I 131 in children, adolescents, and young adults with inoperable relapsed or refractory high-grade gliomas: A trial-in-progress

Meeting Abstract

Sait, S. F.; Morgenstern, D. A.; Pandit-Taskar, N.; Das, A.; Pudel, M.; Fisher, C.; Zanzonico, P.; Haque, S.; Longcor, J.; Shustov, A.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save

Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors

Meeting Abstract

Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
Neuro-Oncology (2024)

Fulltext@MSK | Save